Breast Cancer Experience of the Molecular Tumor Board at the University of California, San Diego Moores Cancer Center
- 1 November 2015
- journal article
- health care-delivery
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 11 (6), 442-449
- https://doi.org/10.1200/jop.2015.004127
Abstract
Multidisciplinary molecular tumor boards may help optimize the management of patients with advanced, heavily pretreated breast cancer who have undergone genomic testing.Keywords
This publication has 22 references indexed in Scilit:
- Cyclin alterations in diverse cancers: outcome and co-amplification networkOncotarget, 2014
- Unique Molecular Landscapes in Cancer: Implications for Individualized, Curated Drug CombinationsCancer Research, 2014
- Molecular Tumor Board: The University of California San Diego Moores Cancer Center ExperienceThe Oncologist, 2014
- Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigmsOncotarget, 2014
- A Targeted Next-Generation Sequencing Assay Detects a High Frequency of Therapeutically Targetable Alterations in Primary and Metastatic Breast Cancers: Implications for Clinical PracticeThe Oncologist, 2014
- Combined analysis of gene expression, DNA copy number, and mutation profiling data to display biological process anomalies in individual breast cancersBreast Cancer Research and Treatment, 2014
- Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cellsCell Death & Disease, 2013
- Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2AAntiviral Research, 2012
- Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancersBreast Cancer Research and Treatment, 2012
- High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1 , that is amplified and overexpressed in oral cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2002